Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.31B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.17B |
| 3 |
Privia Health
PRVA
|
+$1.13B |
| 4 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$1.01B |
| 5 |
Sea Limited
SE
|
+$852M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$960M |
| 2 |
Avantor
AVTR
|
+$895M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$760M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$645M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.59% |
| 2 | Consumer Discretionary | 9.73% |
| 3 | Financials | 8.55% |
| 4 | Healthcare | 8.03% |
| 5 | Communication Services | 6.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
PUT
Invesco Solar ETF
TAN
$1.45B
| $4.91M | ﹤0.01% |
55,000
+40,000
| +267% | +$3.25M |
|
3302
CALL
Altria Group
MO
$114B
| $4.91M | ﹤0.01% |
+102,900
| New | +$5.06M |
|
|
NNDM
3303
Nano Dimension
NNDM
$328M
| $4.9M | ﹤0.01% |
595,107
+417,894
| +236% | +$3.09M |
|
3304
National Beverage
FIZZ
$3.02B
| $4.9M | ﹤0.01% |
103,774
+19,404
| +23% | +$941K |
|
3305
Invesco CurrencyShares Swiss Franc Trust
FXF
$398M
| $4.89M | ﹤0.01% |
50,000
| – | – |
|
3306
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.43B
| $4.89M | ﹤0.01% |
50,000
| – | – |
|
|
ANAT
3307
DELISTED
American National Group, Inc. Common Stock
ANAT
| $4.89M | ﹤0.01% |
32,948
+14,738
| +81% | +$1.97M |
|
3308
PUT
PagSeguro Digital
PAGS
$2.63B
| $4.89M | ﹤0.01% |
+87,500
| New | +$4.21M |
|
3309
Pan American Silver
PAAS
$20.3B
| $4.89M | ﹤0.01% |
170,987
-48,882
| -22% | -$1.58M |
|
3310
PUT
Intuitive Surgical
ISRG
$133B
| $4.87M | ﹤0.01% |
15,900
-5,700
| -26% | -$1.6M |
|
3311
Oil States International
OIS
$502M
| $4.87M | ﹤0.01% |
620,157
-57,125
| -8% | -$382K |
|
3312
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$22.4B
| $4.86M | ﹤0.01% |
109,204
+54,213
| +99% | +$2.09M |
|
|
TRIL
3313
DELISTED
Trillium Therapeutics Inc.
TRIL
| $4.86M | ﹤0.01% |
501,442
+398,567
| +387% | +$3.75M |
|
3314
Plexus
PLXS
$7.35B
| $4.86M | ﹤0.01% |
53,156
-35,321
| -40% | -$3.31M |
|
3315
Valaris
VAL
$5.33B
| $4.86M | ﹤0.01% |
+168,213
| New | +$4.22M |
|
|
RICE.WS
3316
DELISTED
Rice Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise pr
RICE.WS
| $4.84M | ﹤0.01% |
850,000
| – | – |
|
3317
V2X
VVX
$2.44B
| $4.83M | ﹤0.01% |
101,587
-30,564
| -23% | -$1.57M |
|
3318
Haemonetics
HAE
$3.8B
| $4.83M | ﹤0.01% |
72,469
-44,009
| -38% | -$3.11M |
|
|
GLS
3319
DELISTED
Gelesis Holdings, Inc.
GLS
| $4.8M | ﹤0.01% |
490,733
+6,489
| +1% | +$63.8K |
|
|
VIVO
3320
DELISTED
Meridian Bioscience Inc
VIVO
| $4.8M | ﹤0.01% |
216,361
-159,765
| -42% | -$3.39M |
|
3321
Safe Bulkers
SB
$778M
| $4.8M | ﹤0.01% |
1,196,426
+890,792
| +291% | +$3.12M |
|
3322
Arlo Technologies
ARLO
$1.73B
| $4.8M | ﹤0.01% |
708,580
+82,816
| +13% | +$540K |
|
|
PLMIU
3323
DELISTED
Plum Acquisition Corp. I Units
PLMIU
| $4.79M | ﹤0.01% |
484,117
-415,883
| -46% | -$4.15M |
|
|
RNAM
3324
DELISTED
Avidity Biosciences
RNAM
| $4.79M | ﹤0.01% |
193,861
-171,184
| -47% | -$3.98M |
|
3325
Heartland Express
HTLD
$972M
| $4.79M | ﹤0.01% |
279,435
+172,010
| +160% | +$3.18M |
|
Similar funds
Goldman Sachs's Q2 2021 Portfolio in Review
As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 821 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.
- Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
- Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
- Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
- Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
- Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
- Goldman Sachs opened 821 new positions and closed 700 in Q2 2021.
- Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.
Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.